Introduction
The NF-B family of proteins has been reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] to participate in the regulation of numerous genes involved in diverse cellular activities, including cell growth, cell differentiation, immune regulation and stress response. For implementing these functions, the NF-B proteins are regulated by diverse cytokines, including TNF-␣ and ␤, interleukin-1␣ and ␤, and the platelet-derived growth factor PDGF. [9] [10] [11] [12] [13] [14] A variety of other agents, including lipopolysaccharides (LPS), HIV and EpsteinBarr viruses, 1, [14] [15] [16] [17] reactive oxygen intermediates and UV light, have also been described capable of regulating NF-Bmediated events. 1, [14] [15] [16] That multiplicity of signals reflects the central role NF-B plays in coordinating fundamental cellular events. [14] [15] [16] The NF-B family of proteins comprises at least five members, including Rel A (p65), c-Rel (p75), NF-B2 (p52) and its precursor p100, as well as NF-B1 (p50) and its precursor p105. 8, [15] [16] [17] An alternatively spliced form of p65, designated ⌬p65, has also been identified. 15 All these family members exhibit extensive homology at their amino terminal, covering a stretch of 300 amino acids that contains DNA-binding and nuclear-localization domains. [3] [4] [5] [6] In keeping with this multiplicity of structures, the expression and activation of the NF-B proteins has been reported to be regulated at multiple levels, including transcription, posttranslational processing, splicing and intracellular localiz- ation. 13, [17] [18] [19] In unstimulated cells, NF-B (Rel A) proteins are present in the cytoplasm as inactive complexes bound to inhibitory IB proteins. [15] [16] [17] [18] [19] [20] Several of these, including IB␣, ␤, ␥, ⑀, Bcl-3 and p105 have been fully characterized. IB␣ has high affinity for p65 (Rel-A) as well as for p75 (c-Rel), preventing the formation of p65 homodimers and of p50/p65, p52/p65 and p75 (c-Rel) heterodimers (21) (22) (23) (24) . NF-B activating signals release p65 from its complex with IB, allowing its translocation to the nucleus. That release is mediated via phosphorylation and degradation of IBs. 16, 17, 20, [22] [23] [24] [25] [26] [27] Among the targets for regulation by NF-B are the tumor suppressor protein p53 27, 28 and the p53-dependent cyclin kinase inhibitor p21/Cip1 which, as we reported recently, 29 function as differentiation-associated inhibitors of PCNA expression. That inhibition prevents the DNA synthesis required for proliferation-associated G1/S transit, leading to the uncoupling of growth from differentiation and to the expression of the differentiation program. In this communication we report studies on the mechanism by which the p65 (Rel A) and the p52 (NF-B2) members of the NF-B family, participate in the activation of ML-1 cell differentiation.
Materials and methods
Polyclonal antibodies to p65 (Rel A), p75 (c-Rel), p50 (NF-B1), p52 (NF-B2), NIK and IK␣, and monoclonal antibodies to IB␣, were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Molecular weight standards for SDS-PAGE were obtained from Bio-Rad Labs (Hercules, CA, USA). Western blotting reagents and ␥-32 P ATP were supplied by NEN (Boston, MA, USA) and polynucleotide kinase (PNK) by New England Biolabs (Boston, MA, USA). The p53 promoter expression vector 0.7 CAT, was kindly provided by Dr Guillermina Lozano, MD Anderson Cancer Institute (Houston, TX, USA).
Cell cultures
ML-1 human myeloblastic leukemia cells were maintained in RPMI 1640 medium containing 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml of penicillin and 100 g/ml of streptomycin. The cells were maintained in exponential growth at 37°C, in a humidified 5% CO 2 atmosphere. When required for assay, cells were removed from these maintenance cultures, washed with serum-free RPMI 1640 medium, and synchronized for 48 h by incubation at 37°C in RPMI 1640 medium supplemented with 0.05% FBS. This procedure caused more than 85% of the cells to accumulate in G1. 30 The staged cells were washed twice with serum-free RPMI 1640 medium, followed by resuspension in RPMI 1640 medium containing 0.5% FBS, 40 ng/ml IGF-1 and 0.5 g/ml transferrin (Tf) for proliferation of the cells, or with 10 units/ml TNF-␣ for their differentiation to monocytes. 31 The 0.5% serum added to these cultures ensured the viability of the majority of cells during the 72 h incubation period, without 809 significantly affecting their differentiation status. Cell numbers were determined by hemocytometer, and cell viability by trypan blue exclusion. Differentiation was monitored by counting the number of cells expressing the differentiated morphology, and by determining differentiation-associated markers such as Fc receptors, NitroBlueTetrazolium-reducing ability, acid phosphatase activity, phagocytosis and cell adherence. [29] [30] [31] [32] [33] For example, the level of acid phosphatase activity present in ML-1 cells after 24 
Cell extracts
Cytoplasmic and nuclear extracts of ML-1 cells were prepared as described previously. 29, 30 Briefly, 2-4 × 10 7 cells treated with the growth -or differentiation -factors, were washed twice with ice-cold, serum-free RPMI 1640 medium, followed by suspension in 0.15 ml of nuclear isolation buffer consisting of 2 mM MgCl 2 , 5 mM K 2 HPO 4 , 0.1 mM ethylene diamine tetraacetic acid (EDTA), 1 mM phenylmethylsulfonyl fluoride (PMSF), 20 g/ml aprotinin, 20 g/ml leupeptin and 0.1 mM Na 3 VO 4 . An additional 0.15 ml of nuclear buffer, containing 0.7% Triton-X100 was added, and incubation, on ice, proceeded for 8 min. After homogenizing the cells with a Dounce tissue grinder, the homogenate was centrifuged at 150 g. The supernatant, designated the cytoplasmic fraction, was aliquoted and stored at −80°C. The pellet was washed once with nuclear buffer, and the nuclear extract prepared as detailed previously. 29 Briefly, the washed pellet was resuspended in buffer containing 20 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (Hepes), pH 7.9, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM PMSF, 0.5 mM dithiothreitol (DTT), 0.1 mM Na 3 VO 4 , 50 mM NaF, 30 mM pyrophosphate, 20 g/ml leupeptin and 20 g/ml aprotinin, and the nuclei homogenized using a Kontes dual tissue grinder. After centrifugation of the homogenate at 12 000 g, the supernatant, designated the nuclear extract, was frozen and stored at −80°C.
Western blotting
The levels of NIK, IK␣, IB␣ and of the NF-B proteins p50, p52, p65 and p75 present in the cells, were assayed by Western blotting, 29 50 g of nuclear or 100 g of cytoplasmic protein being loaded on to 10% discontinuous polyacrylamide SDS gel. After electrophoresis, the proteins were transferred to nitrocellulose membranes, using a trans-blot electrophoretic transfer cell. The membranes were blocked overnight with 5% milk in phosphate-buffered saline (PBS), followed by incubation with primary antibody for 2 h. After washing once for 15 min and three times for 5 min in PBS containing 0.1% Tween-20, the membranes were incubated with secondary antibody for 1 h, washed extensively as described above, incubated for 1 min in Renaissance Western Blot Chemiluminescence Reagent (NEN), and autoradiographed with Kodak X-omat AR (Rochester, NY, USA) or Dupont NEN films. The films were scanned by densitometer, and the relative levels determined by reference to controls.
Leukemia

Phosphorylation and immunoprecipitation of IK␣
ML-1 cells, synchronized by serum depletion for 48 h, were washed with serum-free RPMI 1640 medium. Cells (1 × 10 7 per treatment group) were then suspended in 10 ml of phosphate-free RPMI 1640 medium containing 0.5% dialyzed fetal calf serum. Cell proliferation was initiated by adding 40 ng/ml IGF-1 + 0.5 g/ml transferrin, and cell differentiation was induced by adding 10 units/ml of TNF-␣. After incubation for 15 and for 21 h periods, the cells were pelleted, washed with phosphate-free RPMI 1640 medium, and resuspended in 1 ml of phosphate-free medium containing 0.5% dialyzed fetal calf serum, the growth -or differentiation -factors, and 100 Ci of 32 P-orthophosphate (3000 Ci/mmol; NEN). Following incubation for 3 h, the cells were collected, washed three times with phosphate-free medium, and the cytosolic extracts prepared as described above. Three hundred l of the extract was precleared with 1 g of normal rabbit IgG, and immunoprecipitates of Ik␣ were prepared as follows: precleared extract, containing approximately 10 6 cpm, was added to 150 l of immunoprecipitation buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP-40, 20 mM EDTA, 0.1 mM Na 3 VO 4 , 50 mM NaF, 1 mM PMSF, 1 mM benzamidine, 10 g/ml trypsin inhibitor, 20 g/ml leupeptin, 20 g/ml aprotinin and 1.5 g of affinity purified anti-IK␣ antibody. After rotating the mixtures for 1 h at 4°C, 30 l of immobilized protein A was added to each mixture and rotation continued overnight. Immunoprecipitates were collected by centrifugation, washed, suspended in 30 l of 2 × sample buffer, followed by analysis on 10% SDS-PAGE. The dried gels were autoradiographed with Kodak X-O mat film.
Electrophoretic mobility shift assay
Identification of NF-B proteins capable of binding to the p53 promoter present in the nuclear extracts from ML-1 cells, was performed as follows: the p53 promoter fragment spanning nucleotides −326 to +348, including the NF-B binding site, was isolated from the plasmid 0.7p53 CAT 28 by HindIII digestion. The fragment was labeled with 32 P-ATP using T4 polynucleotide kinase, and the binding reactions carried out by incubating 10 g of nuclear protein with 10 5 cpm of 32 P-labeled p53 promoter fragment in binding buffer consisting of 10 mM Tris-HCl pH 7.5, 1 mM DTT, 50 mM NaCl, 1 mM EDTA, 0.5% (v/v) glycerol and 1.5 g of poly dI:dC in a final volume of 25 l. Incubation, for 30 min, was carried out at room temperature and the samples were electrophoresed on 5% nondenaturing acrylamide gel for 3 h at 175 V. Specificity of binding was confirmed by the addition of 50 × unlabeled probe. NF-B (p52/p65) present in the complex was detected by incubating the binding reaction mixture with 1.5 g of p52/p65 (NF-B) polyclonal antibody for 30 min (antibody super shift).
Effect of sense and antisense phosphorothioate oligodeoxynucleotides of NF-B (p65) on ML-1 cell differentiation and on the relative level of NF-B (p65) and of p53 expressed
The sense (5Ј TCATCTTCCCGGCAGAGCCAG 3Ј) 10 and the corresponding antisense oligodeoxynucleotides of NF-B (p65) were synthesized by the Roswell Park Cancer Institute Biopolymer facility. One mM stock solutions of these com-pounds were prepared by dissolving them in serum-free RPMI 1640 medium. Five to 25 l aliquots of the stock solutions, together with 3 g of superFect transfection reagent (Qiagen, Chatsworth, CA, USA), were then incubated at 37°C for 15 min, followed by dilution with 100 l of serum-free RPMI 1640 medium and transfer to 1 ml of cell suspension (6 × 10 5 cells/ml). After 2 days of incubation, cell numbers were counted by hemocytometer, viability assessed by trypan blue exclusion and differentiation determined by counting the number of cells displaying differentiated morphology and expressing increased levels of acid phosphatase activity. The levels of p53 and of NF-B (p65) present in ML-1 cells untreated (control) or treated with sense or with antisense oligonucleotides were then assayed by Western blotting as described above.
Results and discussion
Achieving a balance between tumor cell proliferation and tumor cell differentiation constitutes a potentially useful approach for the effective therapy. To achieve this objective requires information on the identity of the molecular effectors that regulate access on to or exclusion from these two paths.
We established previously 31, 33 that, in serum-free RPMI 1640 medium, IGF-1 and transferrin stimulate ML-1 cell growth, whereas TNF-␣ initiates ML-1 cell differentiation. This selectivity provided us with the opportunity to examine the molecular events leading to the inception of ML-1 cell growth or differentiation. Figure 1a shows that treatment of ML-1 cells with the differentiation factor TNF-␣ resulted in the relatively rapid and pronounced decrease in the cytoplasmic level of NF-B (p65) (̃). That decline reached its nadir after approximately 20 h of incubation, recovering its starting level after As shown in Figure 1b , the amount of NF-B (p65) that accumulated in the nucleus of the differentiation-induced ML-1 cells, was quite similar to the amount of NF-B (p65) that was lost from the cytoplasm of these cells (Figure 1a) , suggesting that TNF-␣-induced cell maturation involves a shift of NF-B (p65) from the cytoplasm to the nucleus. In contrast to this result, Figure 1c shows that NF-B (p52) is present in the nuclei of control, of growth-as well as of differentiationinduced cells, but is absent from the cytosolic fraction of these cells (data not shown ). As shown in Figure 1d , NF-B (p75) differs from this pattern insofar as it accumulates in the cytoplasm of differentiating (̃) but not of proliferating (b) or of control (᭺) cells, indicating that its function pertains to cytoplasmic differentiation events. Finally, NF-B (p50) was not detected in either of these cell compartments.
The molecular events involved in bringing about the TNF-␣-mediated translocation of NF-B (p65) from the cytoplasm to the nucleus are delineated in Figure 1e and detailed in Figure 1f-h. They include the expression of NIK, 34 the NF-Binducing kinase that catalyses the phosphorylation of Ik␣. That activation leads to decreased levels of IB, allowing the subsequent translocation of p65 (NF-B) from the cytoplasm to the nucleus. As shown in Figure 1f Determination by EMSA, of heterodimer p52 (B)/p65 (NF-B) binding to the p53 promoter. The p53 promoter fragment spanning nucleotides −326 to +348 labeled with 32 P-ATP and T4 polynucleotide kinase, served as the probe. Binding reactions were carried out by incubating 10 g of nuclear protein with the probe, as described in 'Materials and methods'. p52/p65 (NF-B) complexed with the p53 promoter only in the nuclear extracts from differentiating (D) but not from control (C) or from growing (G) ML-1 cells. The specificity of binding was determined by the use of 50 × unlabeled probe, and the presence of p52 (NF-B) and of p65 (NF-B) in the complex was identified by competition with antibodies to these proteins and by antibody supershift. The free probe runs a considerable distance from the shifted products and is not shown.
(KD83) in differentation (D)-but not in growth (Figure 1g ). This difference in phosphorylation was not accompanied by a significant difference in the level of Ik␣ protein expressed in growth vs differentiation (data not shown). Phosphorylation of IK␣ in differentiation-stimulated cells, was followed by a decrease in the level of IB␣ (Figure 1h) , resulting in the liberation ( Figure 1a ) and translocation (Figure 1b ) of cytoplasmic NF-B (p65) to the nucleus.
Given the observation 28 that NF-KB (p65) is involved in the activation of the tumor suppressor protein p53, we examined the possible regulatory effect (p65) NF-B might exert on p53 Table 1 Effect of sense and antisense oligodeoxynucleotides to the p65 subunit of NF-B on ML-1 cell growth and differentiation, and on the expression of NF-B (p65) and of the tumor suppressor protein p53 5 synchronized ML-1 cells, suspended in RPMI 1640 medium containing 0.5% fetal bovine serum or 10 units/ml of the differentiationinducer TNF-␣, were incubated for 2 days at 37°C. Cell numbers were determined by hemocytometer, and the percentage of differentiated cells assessed by counting the number of cells exhibiting the differentiated phenotype and by determining the increase in level of acid phosphatase activity that resulted. The amount of p65 and p53 protein expressed in the cells was measured by Western blotting and by densitometric scanning.
Leukemia expression in growth-vs differentiation-induced ML-1 cells. Applying EMSA to nuclear extracts from control, from proliferation-and from differentiation-induced ML-1 cells, together with a p53 promoter fragment, 28 we found that, as shown in Figure 2 , a complex consisting of the heterodimer NF-B (p52/p65) was bound to the p53 promoter DNA present in the nuclear extract from differentiation-induced (D), but not from control (C) or from proliferation (G)-stimulated ML-1 cells. In the presence of unlabeled probe, the complex disappeared, indicating that binding was specific. The complex also disappeared when antibody to NF-B p52 or/and to NF-B p65 was added. When the antibodies to NF-B p65 and/or to NF-B p52 were added after the binding reaction, a supershifted band was found present in the nuclear extract from differentiation-induced cells, indicating that these proteins are bound to the p53 promoter fragment.
To gain additional information on the functional role (NF-B) p65 and the tumor suppressor protein p53 might play in the regulation of ML-1 cell growth and differentiation, control (Table 1 , column 1, lines 1-3) and differentiation-induced (column 1, lines 4-6) ML-1 cells were treated with sense and antisense oligodeoxynucleotide fragments of NF-B (p65). As shown in column 2, lines 1-6 of Table 1 , neither the sense nor the antisense oligodeoxynucleotides exerted a significant effect on total cell number. In contrast, they affected the maturation status of the cells, sense oligonucleotides stimulating (column 3, lines 2 and 5), and antisense oligonucleotides inhibiting (column 3, lines 3 and 6) cell differentiation. This signaling activity was reflected in the levels of NF-B (p65) and of p53 that were expressed (columns 4 and 5). The sense oligonucleotides stimulated (lines 2 and 5), whereas the antisense oligonucleotides inhibited the expression of these two proteins, demonstrating that they play a regulatory role in cell growth and cell differentiation. We 29 and others, [35] [36] [37] [38] [39] [40] [41] have shown that p53 is expressed at a high level in the nuclei of differentiation-induced but not of growth-stimulated ML-1 cells, and the data shown in column 4 of Table 1 demonstrate that, in these cells, a parallel exists between the relative level of NF-B (p65) (column 4) and the relative level of p53 (column 5) that is expressed. By binding to the p53 promoter, 29 NF-B (p65) causes the overexpression of p53, leading to the repression of the PCNA promoter, [15] [16] [17] resulting in the inhibition of proliferation-associated DNA synthesis. That inhibition is envisioned to contribute to G1/S arrest, uncoupling of growth from differentiation and to initiation of the differentiation program. The data presented in this paper thus delineate a mechanistic basis for the molecular events involved in tumor cell development, such events providing an opportunity for designing approaches useful for therapeutic intervention.
